The Vascular Patches Market, estimated at USD 443.6 Mn in 2025, is expected to exhibit a CAGR of 7.9% and reach USD 755.3 Mn by 2032.
The industry is witnessing significant growth driven by rising demand for advanced, reliable, and cost-effective medical devices across diagnostic, therapeutic, and monitoring applications. Rapid advancements in device design, digital health integration, and adoption of minimally invasive technologies are reshaping the competitive landscape. Furthermore, supportive regulatory frameworks, increasing healthcare investments, and the growing focus on patient-centric care are expected to create new growth avenues for market players.
Key market players are focusing on adopting growth strategies, such as the launch of new products, which will drive the global vascular patches market. For instance, on February 4, 2019, Cardiva Medical Inc., a medical device company, received premarket approval (PMA) approval from the U.S. Food and Drug Administration (FDA) for the VASCADE MVP Venous Vascular Closure System. VASCADE MVP uses a simple and proprietary delivery system to place a collagen patch on the outside of each vessel puncture site following completion of the procedure.
Global Vascular Patches Market– Impact of Coronavirus (COVID-19) Pandemic
The World Health Organization (WHO) designated the illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan (province of Hubei, China) in the last months of 2019 as "coronavirus disease 2019" or COVID-19. This virus spread quickly and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.
COVID-19 affected the economy in three main ways: by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to the lockdown, several countries, such as India, China, Brazil, and others, faced problems with regard to the transportation of things from one place to another.
COVID-19 impacted the growth of the vascular patch market negatively owing to the decreased number of vascular surgeries due to the restrictions imposed by the government to avoid the spread of COVID-19. For instance, according to an article published in Frontiers in Surgery, on August 2022, during a pandemic, there was a 34.51% drop in surgical procedures reported in central Romania, with a disproportionally large 80.6% drop in cases with a diagnosis of venous insufficiency and a rise of 67.21% in patients with acute arterial ischemia.
Global Vascular Patches Market: Key Developments
On June 26, 2019, Osaka Medical College, Fukui Tateami Co., Ltd., a fabric manufacturing company, and Teijin Limited, a Japanese pharmaceutical and information technology company, announced that the alliance had launched a clinical trial of their newly developed patch material, OFT-G1 (provisional name), for cardiovascular surgery, and the first surgery using OFT-G1 was successfully performed. The OFT-G1 is revolutionary designed by the surgical expertise in cardiovascular surgery of Osaka Medical College, the pioneering warp-knitting technology of Fukui Tateami, and the advanced polymer-application technology of Teijin.